KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.46.

  • Gilead Sciences' EPS (Basic) rose 14600.0% to $2.46 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.51, marking a year-over-year increase of 641000.0%. This contributed to the annual value of $0.38 for FY2024, which is 9145.79% down from last year.
  • Latest data reveals that Gilead Sciences reported EPS (Basic) of $2.46 as of Q3 2025, which was up 14600.0% from $1.57 recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' EPS (Basic) peaked at $2.46 during Q3 2025, and registered a low of -$3.34 during Q1 2024.
  • For the 5-year period, Gilead Sciences' EPS (Basic) averaged around $0.98, with its median value being $1.21 (2021).
  • As far as peak fluctuations go, Gilead Sciences' EPS (Basic) skyrocketed by 395000.0% in 2023, and later tumbled by 51234.57% in 2024.
  • Gilead Sciences' EPS (Basic) (Quarter) stood at $0.3 in 2021, then soared by 337.6% to $1.31 in 2022, then fell by 13.39% to $1.13 in 2023, then rose by 25.95% to $1.43 in 2024, then skyrocketed by 72.14% to $2.46 in 2025.
  • Its EPS (Basic) was $2.46 in Q3 2025, compared to $1.57 in Q2 2025 and $1.06 in Q1 2025.